These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 2334941

  • 21. Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
    Patil V, Gada K, Panwar R, Varvarigou A, Majewski S, Weisenberger A, Ferris C, Tekabe Y, Khaw BA.
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):824-39. PubMed ID: 22302089
    [Abstract] [Full Text] [Related]

  • 22. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
    Buraggi GL, Callegaro L, Mariani G, Turrin A, Cascinelli N, Attili A, Bombardieri E, Terno G, Plassio G, Dovis M.
    Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
    [Abstract] [Full Text] [Related]

  • 23. Two-step targeting and dosimetry for small cell lung cancer xenograft with anti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten.
    Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Faivre-Chauvet A, Gautherot E, Barbet J, Chatal JF.
    J Nucl Med; 1999 Jul; 40(7):1216-21. PubMed ID: 10405144
    [Abstract] [Full Text] [Related]

  • 24. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Fiche M, Gautherot E, Barbet J, Chatal JF.
    J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
    [Abstract] [Full Text] [Related]

  • 25. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG, Beatty BG, Vlahos WG, Porudominsky D, Philben VJ, Williams LE, Paxton RJ, Shively JE, Beatty JD.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [Abstract] [Full Text] [Related]

  • 26. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 27. Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
    Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J.
    J Nucl Med; 2000 Mar 01; 41(3):480-7. PubMed ID: 10716323
    [Abstract] [Full Text] [Related]

  • 28. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF, Boerman OC, Corstens FH, Verheijen RH, Claessens RA, Poels LG, van den Broek WJ, Kenemans P.
    Anticancer Res; 1991 Mar 01; 11(6):2051-7. PubMed ID: 1776839
    [Abstract] [Full Text] [Related]

  • 29. Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.
    Hillairet De Boisferon M, Raguin O, Thiercelin C, Dussaillant M, Rostène W, Barbet J, Pélegrin A, Gruaz-Guyon A.
    Bioconjug Chem; 2002 Mar 01; 13(3):654-62. PubMed ID: 12009958
    [Abstract] [Full Text] [Related]

  • 30. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M, Vihko P, Vihko R.
    Anticancer Res; 1991 Mar 01; 11(3):1327-31. PubMed ID: 1888168
    [Abstract] [Full Text] [Related]

  • 31. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
    Sakahara H, Endo K, Nakashima T, Koizumi M, Kunimatsu M, Kawamura Y, Ohta H, Nakamura T, Tanaka H, Kotoura Y.
    J Nucl Med; 1987 Mar 01; 28(3):342-8. PubMed ID: 3469333
    [Abstract] [Full Text] [Related]

  • 32. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
    Murray JL, Rosenblum MG, Sobol RE, Bartholomew RM, Plager CE, Haynie TP, Jahns MF, Glenn HJ, Lamki L, Benjamin RS.
    Cancer Res; 1985 May 01; 45(5):2376-81. PubMed ID: 3986779
    [Abstract] [Full Text] [Related]

  • 33. Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragment.
    Yokoyama K, Reynolds JC, Paik CH, Sood VK, Maloney PJ, Larson SM, Reba RC.
    J Nucl Med; 1990 Feb 01; 31(2):202-10. PubMed ID: 2313360
    [Abstract] [Full Text] [Related]

  • 34. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
    Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham MM, Hill LD, Beaumier PL, Hellström KE.
    J Clin Invest; 1983 Dec 01; 72(6):2101-14. PubMed ID: 6196380
    [Abstract] [Full Text] [Related]

  • 35. Targeting BCL1 lymphoma with anti-idiotype antibodies: biodistribution kinetics of directly labeled antibodies and bispecific antibody-targeted bivalent haptens.
    Manetti C, Rouvier E, Gautherot E, Loucif E, Barbet J, Le Doussal JM.
    Int J Cancer; 1997 Jun 11; 71(6):1000-9. PubMed ID: 9185704
    [Abstract] [Full Text] [Related]

  • 36. Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.
    van Schaijk FG, Boerman OC, Soede AC, McBride WJ, Goldenberg DM, Corstens FH, Oosterwijk E.
    Eur J Nucl Med Mol Imaging; 2005 Sep 11; 32(9):1089-95. PubMed ID: 15902440
    [Abstract] [Full Text] [Related]

  • 37. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 38. Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice.
    Khaw BA, Strauss HW, Cahill SL, Soule HR, Edgington T, Cooney J.
    J Nucl Med; 1984 May 15; 25(5):592-603. PubMed ID: 6726438
    [Abstract] [Full Text] [Related]

  • 39. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments.
    Schott ME, Frazier KA, Pollock DK, Verbanac KM.
    Bioconjug Chem; 1993 May 15; 4(2):153-65. PubMed ID: 7873647
    [Abstract] [Full Text] [Related]

  • 40. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
    Karacay H, McBride WJ, Griffiths GL, Sharkey RM, Barbet J, Hansen HJ, Goldenberg DM.
    Bioconjug Chem; 2000 May 15; 11(6):842-54. PubMed ID: 11087333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.